Programs address HPV insurance coverage
Two new programs have been announced by Merck & Co. to help confirm patients' insurance coverage and address providers' reimbursement concerns regarding Gardasil, the quadrivalent human papillomavirus (HPV) vaccine.
The Confidence in Coverage Status program provides clinicians with patients' insurance benefit information prior to office visits. Providers who participate in the program will be able to determine which of their privately insured 19- to 26-year-old female patients who are scheduled for office visits in the next one to two weeks have coverage for the HPV vaccination.
By submitting patients' names, birth dates, and insurance information, as well as relevant provider information, to a web site, www.vaccinesupportservices.com, or faxing information to a toll-free number, (866) 209-9051, providers will receive faxed reports within three to five days that include coverage status and, if applicable, copay, coinsurance, and deductible amounts.
Eligible privately insured 19- to 26-year-old female patients who receive Gardasil doses from April 1, 2009, through April 30, 2010, will be eligible for a rebate through the second program, the Patient Rebate Program for Gardasil, when their out-of-pocket costs for Gardasil exceed $30 per dose. The maximum rebate is $130 per dose.
Information about both programs is available at www.gardasil.com/rebate. To request rebate forms, call 800-GARDASIL [(800) 427-3274].
Two new programs have been announced by Merck & Co. to help confirm patients' insurance coverage and address providers' reimbursement concerns regarding Gardasil, the quadrivalent human papillomavirus (HPV) vaccine.You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content